Mylan to Acquire King for US$4 B
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 51 (Table of Contents)
Published: 4 Sep-2004
DOI: 10.3833/pdr.v2004.i51.784 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Mylan Laboratories entered into an agreement to acquire King Pharmaceuticals, thus substantially expanding its pharmaceutical product portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS